Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 11/20 | 0.65 |
| ▸ | HCRTR2 | O43614 | 11/20 | 0.65 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4238426 | 0.82 | HCRTR1 (0.65) | HCRTR1HCRTR2LMNATSHRNPSR1 | |
| SCHEMBL3661610 | 0.82 | HCRTR1 (0.65) | HCRTR1HCRTR2LMNATSHRNPSR1 | |
| SCHEMBL1672311 | 0.79 | HCRTR1 (1.00) | HCRTR1HCRTR2 | |
| SCHEMBL11907856 | 0.78 | HCRTR1 (0.74) | HCRTR1HCRTR2LMNATSHRNPSR1 | |
| Hydrochloric Acid SCHEMBL9960122 | 0.77 | HCRTR1 (0.53) | HCRTR1HCRTR2LMNATSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL9960124 | 0.77 | HCRTR1 (0.53) | HCRTR1HCRTR2LMNATSHRALDH1A1 | |
| SCHEMBL1586124 | 0.77 | HCRTR1 (0.67) | HCRTR1HCRTR2LMNATSHRNPSR1 | |
| SCHEMBL19893922 | 0.75 | HCRTR1 (0.56) | HCRTR1HCRTR2LMNATSHRNPSR1 | |
| SCHEMBL1586847 | 0.75 | HCRTR1 (0.56) | HCRTR1HCRTR2 | |
| SCHEMBL1586290 | 0.75 | HCRTR1 (0.56) | HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011050200-A1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-04-28 | — | — | WO | disclosed |